Markets:

Overview

News

Currencies

International

Treasuries

MannKind Corporation - Common Stock (NQ:MNKD)

5.628 -0.042 (-0.75%)

Streaming Delayed Price Updated: 1:06 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MannKind Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Looking Into MannKind's Return On Capital Employed ↗

February 27, 2023

Via Benzinga

MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday ↗

February 27, 2023

Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...

Via Benzinga

Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday ↗

February 24, 2023

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.

Via Benzinga

MannKind (MNKD) Q4 2022 Earnings Call Transcript ↗

February 24, 2023

MNKD earnings call for the period ending December 31, 2022.

Via The Motley Fool

MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results

February 23, 2023

Conference Call to Begin Today at 5:00 p.m. (ET)

From MannKind

Via GlobeNewswire

MannKind Earnings Preview ↗

February 22, 2023

Via Benzinga

MannKind's Return On Capital Employed Overview ↗

December 05, 2022

Via Benzinga

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference

February 22, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023

February 16, 2023

From MannKind

Via GlobeNewswire

Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference

February 10, 2023

From MannKind

Via GlobeNewswire

MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript ↗

November 08, 2022

MNKD earnings call for the period ending September 30, 2022.

Via The Motley Fool

MannKind: Q2 Earnings Insights ↗

August 09, 2022

MannKind (NASDAQ:MNKD) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

MannKind Corporation to Participate in the Lytham Partners Investor Select Conference

January 24, 2023

From MannKind

Via GlobeNewswire

MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease

January 23, 2023

From MannKind

Via GlobeNewswire

3 Biotech Stocks Under $15 Worth a Second Look in 2023 ↗

January 18, 2023

All three stocks have promising therapies that could drive revenue in the coming years.

Via The Motley Fool

MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference

January 05, 2023

From MannKind

Via GlobeNewswire

MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting

November 10, 2022

From MannKind

Via GlobeNewswire

MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday ↗

November 09, 2022

Via Benzinga

Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33% ↗

November 09, 2022

B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading.

Via Benzinga

MannKind Corporation Reports 2022 Third Quarter Financial Results

November 08, 2022

Conference Call to Begin Today at 9:00 a.m. (ET)

From MannKind

Via GlobeNewswire

Earnings Preview: MannKind ↗

November 07, 2022

MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...

Via Benzinga

MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022

November 01, 2022

From MannKind

Via GlobeNewswire

7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up ↗

September 29, 2022

While these market ideas are risky, they offer enough relevance to be intriguing.

Via InvestorPlace

7 Penny Stocks That Actually Have a Buy Rating ↗

September 19, 2022

Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.

Via InvestorPlace

MannKind Shares Fall After Completing Initial Stage Lung Disease Study ↗

September 06, 2022

MannKind Corporation (NASDAQ: MNKD) has successfully completed a Phase 1 study of clofazimine inhalation suspension (MNKD 101), an inhalation treatment option for nontuberculous mycobacterial (NTM)...

Via Benzinga

Earnings Outlook For MannKind ↗

August 08, 2022

MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...

Via Benzinga

Jim Cramer Recommends Selling This Stock: 'No One Ever Likes Me To Say Anything Bad' About This Company ↗

August 04, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Canoo Inc. (NASDAQ: GOEV) is losing money. "We’re done with those stocks that just lose money," he added.

Via Benzinga

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation ↗

May 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Biotech Stocks With Key Catalysts for May ↗

May 11, 2022

The beaten-down state of biotech stocks is a major pulling point for investors who are aiming for market-leading returns.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.